CD8A and glioma: However, in mice orthotopically implanted with either CT2A or SMA-560 glioma cells, TILs displayed a significantly greater CD8+ T cell percentage of TIM-3 positivity compared to peripheral CD8+ T cells from glioma cell implanted mice and healthy mice [101].